节点文献

17β-雌二醇与N-甲基-N-硝基-N-亚硝基胍诱导ICR小鼠子宫内膜癌的研究

Study on the induction of endometrial cancer in ICR mice by 17beta-estradiol and N-methy-N-nitro-N-nitrosoguanidine.

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张玉泉滕晓东施公胜朱顺星史锦云

【Author】 Zhang Yuquan1,Teng Xiaodong2,Shi Gongsheng3,et al.1.Department of Obstetrics and Gynecology,the Affiliated Hospital of Nantong Medical College,Nantong 226001;2.Department of Pathology,the 2nd Affiliated Hospital of Nantong Medical College;3.Department of

【机构】 南通医学院附属医院妇产科!南通226001南通医学院第二附属医院病理科南通医学院附属医院病理科南通医学院动物部

【摘要】 目的 :用 17β 雌二醇 (E2 )与N 甲基 N 硝基 N 亚硝基胍 (MNNG)诱导ICR小鼠子宫内膜癌 ,研究子宫内膜癌变的诱发因素。方法 :选择 6周龄ICR雌性小鼠 90只 ,分为 4组。Ⅰ组 (空白对照组 ) ,小鼠 12只 ,常规喂养 ;Ⅱ组 (MNNG +E2 组 ) ,小鼠 2 6只 ,经阴道宫腔给予MNNG ,每周 1次 ,共 3次 ,在给予MNNG的同时喂E2 ;Ⅲ组 (MNNG组 ) :小鼠2 6只 ,仅给予MNNG ;Ⅳ组 (E2 组 ) :小鼠 2 6只 ,仅给予E2 。于实验后 3个月、6个月及 9个月各组取若干只小鼠 ,测定血清雌激素 (E)及孕酮 (P) ,并作子宫内膜病理组织学检查。结果 :实验 3个月时 ,Ⅳ组子宫内膜发生复杂型 (3 5 )或不典型增生性改变 (2 5 ) ;实验 6个月时 ,Ⅱ组、Ⅲ组、Ⅳ组均有部分发生复杂型或不典型增生过长及癌变 ,但 3组间差异无显著性 (P >0 .0 5 ) ;实验 9个月时Ⅱ组复杂型增生、不典型增生、内膜癌分别为 35 .7% (5 14)、2 8.6% (4 14)、35 .7% (5 14) ,Ⅳ组以上病变分别为 14.3% (2 14)、4 2 .9% (6 14)、4 2 .9%(6 14) ,Ⅱ组、Ⅳ组间相比差异无显著性 (P >0 .0 5 )。实验 6个月与 9个月时 ,喂E2 组E P均明显高于喂水组 (P <0 .0 1或P <0 .0 5 )。结论 :单独给予E2 或MNNG后 ,即能较好地诱发子宫内膜癌。E2 与MNNG联合给药时 ,效果并未较?

【Abstract】 Objective:To develop an animal model for endometrial neoplasms in ICR mice treated with 17beta-estradiol(E 2) and N-methy-N-nitro-N-nitrosoguanidine(MNNG). Methods:A total of 90 female ICR mice,6 weeks of age,were treated as follows:Group 1(12 mice) was fed with water.Group 2(26 mice) was given intravaginal instillation of MNNG solution once a week for three weeks and fed diet containing E 2.Group 3(26 mice) was given MNNG alone.Group 4(15 mice) was given E 2 diet alone.Small numbers of animals in four groups were killed at 3,6 and 9 experimental months for uterine histological and endocrinological examination.Results:At 3 experimental months,endometrial complex hyperplasia(3/5) and atypical hyperplasia(2/5) were found in group 4.At 6 experimental months,there were some complex hyperplasia,atypical hyperplasia and cancer in group 2,3,4,but with no significant difference within the three groups.At 9 experimental months,the incidences of complex hyperplasia of endometrium,atypical hyperplasia and endometrial cancer were 35.7%(5/14),28.6%(4/14),35.7%(5/14) respectively in group 2 and 14.3%(2/14),42.9%(6/14),42.9%(6/14) respectively in group 4.The E/P ratio in mice fed with E 2 was significantly higher than that with water at 6 experimental months (P<0.01)and 9 experimental months(P<0.05).Conclusions:There are many complex or atypical hyperplasias of endometrium and endometrial cancers in mice treated with E 2 or MNNG singly.Combined therapy is not better than single therapy.Increased E/P ratio might act as a promoter of development of endometrial proliferative lesions.

  • 【文献出处】 现代妇产科进展 ,Current Advances In Obstetrics and Gynecology , 编辑部邮箱 ,2001年05期
  • 【分类号】R737.33
  • 【被引频次】2
  • 【下载频次】98
节点文献中: 

本文链接的文献网络图示:

本文的引文网络